Y. Mouton

Publication List Details

Period

1990 - 1994

Number

12

Co-Authors

A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections (1993)

Mouton, Y., Chidiac, C., Humbert, G., Leroy, J., Veyssier, P., Modai, J., ...

Multi-resistant strains of Gram-negative bacteria are rapidly emerging as a frequent cause of serious bacterial infection in the hospital environment. Effective treatment must include an antibiotic...

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections (1993)

Mouton, Y., Leroy, O., Beuscart, C., Chidiac, C., Senneville, E., Ajana, F., ...

An open, non-comparative multicentre study was conducted at 36 sites in six countries to test the efficacy and safety of piperacillin/tazobactam in the therapy of lower respiratory tract infections....

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients (1990)

Mouton, Y., Leroy, O., Beuscart, C., Sivery, B., Senneville, E., Chidiac, C., ...

The efficacy of intravenous ofloxacin therapy (200 mg 12-hourly) foUowed, when appropriate, by oral administration of the same dose was evaluated in an open multicentre trial involving 185 patients...

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Dubreuil, L, Houcke, I, Mouton, Y, Rossignol, J F

The antibacterial activities of nitazoxanide and its main metabolite, tizoxanide, were tested against a broad range of bacteria, including anaerobes. Metronidazole, amoxicillin,...

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Dubreuil, L, Houcke, I, Mouton, Y, Rossignol, J F

The antibacterial activities of nitazoxanide and its main metabolite, tizoxanide, were tested against a broad range of bacteria, including anaerobes. Metronidazole, amoxicillin,...

Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity.

Hober, D, Haque, A, Wattre, P, Beaucaire, G, Mouton, Y, Capron, A

We measured simultaneously circulating and cell-generated TNF-alpha and IL-1 after lipopolysaccharide (LPS) stimulation of peripheral blood mononuclear cells (PBMC) by radioimmunoassay (RIA) in...

Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells

BAHR, G M, DARCISSAC, E C A, MOUTON, Y

Use of interleukin-2 (IL-2) in the immunotherapy of human immunodeficiency virus (HIV) has frequently resulted in the restoration of CD4 lymphocyte counts but not of virus-specific responses. We...

Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)

Idziorek, T, Khalife, J, Billaut-Mulot, O, Hermann, E, Aumercier, M, Mouton, Y, ...

The chemoattractant cytokine IL-16 has been reported to suppress lymphocyte activation and to inhibit HIV-1 replication in acutely infected T cells. We have cloned and expressed human IL-16 in...

Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac−2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy

Darcissac, E C A, Vidal, V, Mouton, Y, Bahr, G M

Serum levels of interleukin-7 (IL-7), a non-redundant cytokine that plays a crucial role in lymphopoiesis, are known to be elevated in HIV-1-infected subjects. To examine further the association...

Telemedicine for AIDS patients accommodations.

Kulik, J. F., Bricon-Souf, N., Beuscart, R. J., Mouton, Y.

People suffering from AIDS are subject to frequent hospitalisations. In some cases, they cannot go back home after hospitalisations, due to severe illness, family or sociologic problems. This is the...